104 related articles for article (PubMed ID: 8041517)
1. Appearance of localized immunoreactivity for the alpha 4 integrin subunit and for fibronectin in brains from Alzheimer's, Lewy body dementia patients and aged controls.
Van Gool D; Carmeliet G; Triau E; Cassiman JJ; Dom R
Neurosci Lett; 1994 Mar; 170(1):71-3. PubMed ID: 8041517
[TBL] [Abstract][Full Text] [Related]
2. alpha 2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease.
Van Gool D; De Strooper B; Van Leuven F; Triau E; Dom R
Neurobiol Aging; 1993; 14(3):233-7. PubMed ID: 7686641
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease.
Lippa CF; Schmidt ML; Lee VM; Trojanowski JQ
Ann Neurol; 1999 Mar; 45(3):353-7. PubMed ID: 10072050
[TBL] [Abstract][Full Text] [Related]
4. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
5. Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodies.
Higashi S; Moore DJ; Minegishi M; Kasanuki K; Fujishiro H; Kabuta T; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Sato K; Arai H; Wada K; Iseki E
J Neuropathol Exp Neurol; 2011 Apr; 70(4):264-80. PubMed ID: 21412173
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate expression patterns in the amyloid deposits of patients with Alzheimer's and Lewy body type dementia.
Van Gool D; David G; Lammens M; Baro F; Dom R
Dementia; 1993; 4(6):308-14. PubMed ID: 8136893
[TBL] [Abstract][Full Text] [Related]
7. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.
Furuta A; Price DL; Pardo CA; Troncoso JC; Xu ZS; Taniguchi N; Martin LJ
Am J Pathol; 1995 Feb; 146(2):357-67. PubMed ID: 7856748
[TBL] [Abstract][Full Text] [Related]
8. Amyloid precursor protein accumulation in Lewy body dementia and Alzheimer's disease.
Van Gool D; De Strooper B; Van Leuven F; Dom R
Dementia; 1995; 6(2):63-8. PubMed ID: 7606281
[TBL] [Abstract][Full Text] [Related]
9. The Lewy body variant of Alzheimer disease.
Hansen LA
J Neural Transm Suppl; 1997; 51():83-93. PubMed ID: 9470130
[TBL] [Abstract][Full Text] [Related]
10. Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome.
Fergusson J; Landon M; Lowe J; Dawson SP; Layfield R; Hanger DP; Mayer RJ
Neurosci Lett; 1996 Nov; 219(3):167-70. PubMed ID: 8971806
[TBL] [Abstract][Full Text] [Related]
11. Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated.
Hanger DP; Brion JP; Gallo JM; Cairns NJ; Luthert PJ; Anderton BH
Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):99-104. PubMed ID: 1826835
[TBL] [Abstract][Full Text] [Related]
12. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
Ikeda S; Allsop D; Glenner GG
Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
[TBL] [Abstract][Full Text] [Related]
13. Neuritic plaques in the Lewy body variant of Alzheimer disease lack paired helical filaments.
Samuel W; Crowder R; Hofstetter CR; Hansen L
Neurosci Lett; 1997 Feb; 223(2):73-6. PubMed ID: 9089676
[TBL] [Abstract][Full Text] [Related]
14. Lewy body variant of Alzheimer's disease and Alzheimer's disease: a comparative immunohistochemical study.
Szpak GM; Lewandowska E; Lechowicz W; Bertrand E; Wierzba-Bobrowicz T; Gwiazda E; Pasennik E; Kosno-Kruszewska E; Lipczyńska-Lojkowska W; Bochyńska A; Fiszer U
Folia Neuropathol; 2001; 39(2):63-71. PubMed ID: 11680637
[TBL] [Abstract][Full Text] [Related]
15. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
Papasozomenos SC
Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
[TBL] [Abstract][Full Text] [Related]
17. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
[TBL] [Abstract][Full Text] [Related]
18. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
Higuchi M; Tashiro M; Arai H; Okamura N; Hara S; Higuchi S; Itoh M; Shin RW; Trojanowski JQ; Sasaki H
Exp Neurol; 2000 Apr; 162(2):247-56. PubMed ID: 10739631
[TBL] [Abstract][Full Text] [Related]
19. A pathological study of the association between Lewy body disease and Alzheimer's disease.
Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
[TBL] [Abstract][Full Text] [Related]
20. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
